Skip to search formSkip to main contentSkip to account menu

Schedule II Substance

Known as: C-II, CII, SPL DEA Schedule II 
A category of drugs considered to have a strong potential for abuse or addiction but that also have legitimate medical use.
National Institutes of Health

Related topics

Related topics

1 relation
Structured Product Labeling DEA Schedule Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2010
Review
2010
A 158 μm [C ii] LINE SURVEY OF GALAXIES AT z ∼ 1–2: AN INDICATOR OF STAR FORMATION IN THE EARLY UNIVERSE
We have detected the 158 μm [C ii] line from 12 galaxies at z ∼ 1–2. This is the first survey of this important star formation… 
Highly Cited
2009
Highly Cited
2009
Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritis
Antibodies to citrulline-modified proteins have a high diagnostic value in rheumatoid arthritis (RA). However, their biological… 
Highly Cited
2008
Highly Cited
2008
α-Tocopheryl succinate induces apoptosis by targeting ubiquinone-binding sites in mitochondrial respiratory complex II
α-Tocopheryl succinate (α-TOS) is a selective inducer of apoptosis in cancer cells, which involves the accumulation of reactive… 
Highly Cited
2002
Highly Cited
2002
Predominant selection of T cells specific for the glycosylated collagen type II epitope (263–270) in humanized transgenic mice and in rheumatoid arthritis
Rheumatoid arthritis (RA) is associated with certain MHC class II alleles and is characterized by a chronic autoimmune response… 
Highly Cited
2002
Highly Cited
2002
Sites of collagenase cleavage and denaturation of type II collagen in aging and osteoarthritic articular cartilage and their relationship to the distribution of matrix metalloproteinase 1 and matrix…
OBJECTIVE To determine the sites of cleavage and denaturation of type II collagen (CII) by collagenase(s) in healthy and… 
Highly Cited
1997
Highly Cited
1997
Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice.
To determine the importance of macrophage migration inhibitory factor (MIF) in the development of arthritis we used an… 
Highly Cited
1997
Highly Cited
1997
An HLA-DR1 Transgene Confers Susceptibility to Collagen-induced Arthritis Elicited with Human Type II Collagen
Rheumatoid arthritis (RA) is an autoimmune disease that is strongly associated with the expression of several HLA-DR haplotypes… 
Highly Cited
1995
Highly Cited
1995
Biphasic effect of interferon‐γ in murine collagen‐induced arthritis
Interferon‐γ (IFN‐γ) exerts both enhancing and suppressing influences on collagen‐induced arthritis (CIA), depending on the route… 
Highly Cited
1990
Highly Cited
1990
Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen.
Adjuvant arthritis is induced by intradermal injection of Mycobacterium tuberculosis (MT) in oil. The role of immunity to type II… 
Highly Cited
1985
Highly Cited
1985
Genetic susceptibility to murine collagen II autoimmune arthritis. Proposed relationship to the IgG2 autoantibody subclass response, complement C5, major histocompatibility complex (MHC) and non-MHC…
Analysis of the IgG autoantibody subclass response in the collagen II autoimmune arthritis (CII AIA)-susceptible D1 strain mice… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)